Shaorong Zhao - Concepedia

Author

Shaorong Zhao

Tianjin Medical University Cancer Institute and Hospital

Also Known As

Shao-Rong Zhao, Shaorong Zhao

Publications

538

Citations

H-Index

Concepts

All Affiliations

Tianjin Medical University Cancer Institute and Hospital Nankai University Tianjin Medical University Wake Forest University Tianjin First Center Hospital

About

Shaorong Zhao is an author at Tianjin Medical University Cancer Institute and Hospital specializing in medicine, cell biology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	141
2	Cell Biology	5	5	141
3	Pathology	2	2	67
4	Cancer Cell Biology	1	1	15
5	Cell Signaling	1	1	20

Shaorong Zhao

Publications

487

Citations

H-Index

Page 1

	Year	Citations
Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling Qianxi Yang, Shaorong Zhao, Zhendong Shi, Journal of Experimental & Clinical Cancer Research	2021	153
Exosomal miR-451a Functions as a Tumor Suppressor in Hepatocellular Carcinoma by Targeting LPIN1 Shaorong Zhao, Jianjun Li, Guomin Zhang, Cellular Physiology and Biochemistry	2019	77
Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1 Qiong Wang, Guanwen Wang, Lianjie Niu, Journal of Oncology OncologyAngiogenesisTumor MicroenvironmentTargeting Smek1Exosomal Secretion	2021	52
Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer Yan Fang, Juan Wang, Guanwen Wang, Oncotarget	2017	44
Exosomal transfer of miR-181b-5p confers senescence-mediated doxorubicin resistance via modulating BCLAF1 in breast cancer Shaorong Zhao, Teng Pan, Jinhai Deng, British Journal of Cancer Tumor BiologyMedicineCancer GenomicsCellular SenescenceBreast Cancer	2022	41
Chidamide Combined With Doxorubicin Induced p53-Driven Cell Cycle Arrest and Cell Apoptosis Reverse Multidrug Resistance of Breast Cancer Lixia Cao, Shaorong Zhao, Qianxi Yang, Frontiers in Oncology	2021	25
Alternative Splice Variants Modulates Dominant-Negative Function of Helios in T-Cell Leukemia Shaorong Zhao, Wei Liu, Yinghui Li, PLoS ONE Hematological MalignancyChromatinDistinct Helios IsoformsSystems BiologyChromatin Remodeling	2016	20
GPRC5A Is a Negative Regulator of the Pro-Survival PI3K/Akt Signaling Pathway in Triple-Negative Breast Cancer Lu Yang, Shaorong Zhao, Tong Zhu, Frontiers in Oncology	2021	19
miR‑95 promotes osteosarcoma growth by targeting SCNN1A Yannan Geng, Shaorong Zhao, Yutao Jia, Oncology Reports Os Cell LinesEpigenetic RegulationMedicineOs Tumor GrowthPathology	2020	15
Pingchan Granule for Motor Symptoms and Non-Motor Symptoms of Parkinson’s Disease: A Randomized, Double-Blind, Placebo-Controlled Study Si‐Chun Gu, Qing Ye, Changde Wang, Frontiers in Pharmacology	2022	15

Page 1